Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Acetónido de fluocinolona")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 51

  • Page / 3
Export

Selection :

  • and

Management of Fluocinolone Implant Dissociation During Implant ExchangeYEH, Steven; CEBULLA, Colleen M; WITHERSPOON, S. Robert et al.Archives of ophthalmology (1960). 2009, Vol 127, Num 9, pp 1218-1221, issn 0003-9950, 4 p.Article

Sustained Ocular Delivery of Fluocinolone Acetonide by an Intravitreal InsertCAMPOCHIARO, Peter A; HAFIZ, Gulnar; KAPIK, Barry et al.Ophthalmology (Rochester, MN). 2010, Vol 117, Num 7, pp 1393-1399, issn 0161-6420, 7 p.Article

Inhibition of Neovascularization but Not Fibrosis With the Fluocinolone Acetonide Implant in Autosomal Dominant Neovascular Inflammatory VitreoretinopathyTLUCEK, Paul S; FOLK, James C; ORIEN, Jason A et al.Archives of ophthalmology (1960). 2012, Vol 130, Num 11, pp 1395-1401, issn 0003-9950, 7 p.Article

Treatment of Posterior Uveitis With a Fluocinolone Acetonide Implant : Three-Year Clinical Trial Results. CommentaryCALLANAN, David G; JAFFE, Glenn J; MARTIN, Daniel F et al.Archives of ophthalmology (1960). 2008, Vol 126, Num 9, issn 0003-9950, 1191-1201, 1287-1289 [14 p.]Article

Effect of percutaneous absorption of fluocinolone acetonide on the activity of superoxide dismutase and total antioxidant status in patients with psoriasisGAVAN, N; POPA, R; ORASAN, R et al.Skin pharmacology. 1997, Vol 10, Num 4, pp 178-182, issn 1011-0283Article

Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular EdemaCAMPOCHIARO, Peter A; BROWN, David M; REICHEL, Elias et al.Ophthalmology (Rochester, MN). 2012, Vol 119, Num 10, pp 2125-2132, issn 0161-6420, 8 p.Article

Expression of IFN-γ before and after treatment of oral lichen planus with 0.1% fluocinolone acetonide in orabaseYOUNGNAK-PIBOONRATANAKIT, Pornpan; DHANUTHAI, Kittipong; THONGPRASOM, Kobkan et al.Journal of oral pathology & medicine. 2009, Vol 38, Num 9, pp 689-694, issn 0904-2512, 6 p.Article

Efficacy and safety of a new triple-combination agent for the treatment of facial melasmaTAYLOR, Susan C; TOROK, Helen; PARISER, David et al.Cutis (New York, NY). 2003, Vol 72, Num 1, pp 67-72, issn 0011-4162, 6 p.Article

A Comparison Between the Fluocinolone Acetonide (Retisert) and Dexamethasone (Ozurdex) Intravitreal Implants in UveitisARCINUE, Cheryl A; CERON, Olga M; FOSTER, C. Stephen et al.Journal of ocular pharmacology and therapeutics. 2013, Vol 29, Num 5, pp 501-507, issn 1080-7683, 7 p.Article

Management of Sympathetic Ophthalmia with the Fluocinolone Acetonide ImplantMAHAJAN, Vinit B; GEHRS, Karen M; GOLDSTEIN, Debra A et al.Ophthalmology (Rochester, MN). 2009, Vol 116, Num 3, pp 552-557, issn 0161-6420, 6 p.Article

Les corticoïdes retards intravitréens: Présentation de trois moléculesBAILLIF, Stéphanie.Pratiques en ophtalmologie. 2014, Vol 8, Num 70, pp 22-25, issn 2106-9735, 4 p.Article

Evaluation of Fluocinolone Acetonide Sustained Release Implant (Retisert) Dissociation during Implant Removal and Exchange SurgeryNICHOLSON, Benjamin P; SINGH, Rishi P; SEARS, Jonathan E et al.American journal of ophthalmology. 2012, Vol 154, Num 6, pp 969-973, issn 0002-9394, 5 p.Article

Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular EdemaCAMPOCHIARO, Peter A; BROWN, David M; GONDER, John et al.Ophthalmology (Rochester, MN). 2011, Vol 118, Num 4, pp 626-635, issn 0161-6420, 10 p.Article

Fluocinolone Acetonide 0.01% in Peanut Oil: Safety and Efficacy Data in the Treatment of Childhood Atopic Dermatitis in Infants as Young as 3 Months of AgeDOHIL, Magdalene A; ALVAREZ-CONNELLY, Elizabeth; EICHENFIELD, Lawrence F et al.Pediatric dermatology. 2009, Vol 26, Num 3, pp 262-268, issn 0736-8046, 7 p.Article

A Histological Examination for Skin Atrophy After 6 Months of Treatment With Fluocinolone Acetonide 0.01 %, Hydroquinone 4%, and Tretinoin 0.05% CreamBHAWAN, Jag; GRIMES, Pearl; PANDYA, Amit G et al.The American journal of dermatopathology. 2009, Vol 31, Num 8, pp 794-798, issn 0193-1091, 5 p.Article

Reimplantation of a Fluocinolone Acetonide Sustained Drug Delivery Implant for Chronic UveitisJAFFE, Glenn J.American journal of ophthalmology. 2008, Vol 145, Num 4, pp 667-675, issn 0002-9394, 9 p.Article

Topical fluocinolone acetonide acetate ointment in autosomal dominant congenital hypotrichosisPASRICHA, J. S; D'SOUZA, P.Indian Journal of Dermatology Venereology and Leprology. 1996, Vol 62, Num 4, pp 242-245, issn 0378-6323Article

Intraocular Pressure Outcome of Patients with Fluocinolone Acetonide Intravitreal Implant for Noninfectious UveitisBOLLINGER, Kathryn; KIM, James; LOWDER, Careen Y et al.Ophthalmology (Rochester, MN). 2011, Vol 118, Num 10, pp 1927-1931, issn 0161-6420, 5 p.Article

Cytomegalovirus endotheliitis following fluocinolone acetonide (Retisert) implantSIMS, J. L; CHEE, S. P.Eye (London. 1987). 2010, Vol 24, Num 1, pp 197-198, issn 0950-222X, 2 p.Article

Photoreceptor Neuroprotection in RCS Rats via Low-Dose Intravitreal Sustained-Delivery of Fluocinolone AcetonideGLYBINA, Inna V; KENNEDY, Alexander; ASHTON, Paul et al.Investigative ophthalmology & visual science. 2009, Vol 50, Num 10, pp 4847-4857, issn 0146-0404, 11 p.Article

Fluocinolone acetonide Sustained drug delivery device to treat severe uveitisJAFFE, Glenn J; BEN-NUN, Joshua; HONG GUO et al.Ophthalmology (Rochester, MN). 2000, Vol 107, Num 11, pp 2024-2033, issn 0161-6420Article

Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical TrialANDREW PEARSON, P; COMSTOCK, Timothy L; IP, Michael et al.Ophthalmology (Rochester, MN). 2011, Vol 118, Num 8, pp 1580-1587, issn 0161-6420, 8 p.Article

Outcomes of Birdshot Chorioretinopathy Treated With an Intravitreal Sustained-Release Fluocinolone Acetonide-Containing DeviceRUSH, Ryan B; GOLDSTEIN, Debra A; CALLANAN, David G et al.American journal of ophthalmology. 2011, Vol 151, Num 4, pp 630-636, issn 0002-9394, 7 p.Article

Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery deviceJAFFE, Glenn J; CHANG HAO YANG; HONG GUO et al.Investigative ophthalmology & visual science. 2000, Vol 41, Num 11, pp 3569-3575, issn 0146-0404Article

Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment TrialKEMPEN, John H; ALTAWEEL, Michael M; HOLBROOK, Janet T et al.Ophthalmology (Rochester, MN). 2011, Vol 118, Num 10, pp 1916-1926, issn 0161-6420, 11 p.Article

  • Page / 3